Exemestane
Suppliers
Names
[ CAS No. ]:
107868-30-4
[ Name ]:
Exemestane
[Synonym ]:
Exemestan
6-Methylenandrosta-1,4-diene-3,17-dione
(8R,9S,10R,13S,14S)-10,13-diméthyl-6-méthylidène-7,8,9,10,11,12,13,14,15,16-décahydro-3H-cyclopenta[a]phénanthrène-3,17(6H)-dione
6-methylenandrost-1,4-diene-3,17-dione
Aromasin
Exemestane
androsta-1,4-diene-6-methylene-3,17-dione
(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione
Exemestance
6-Methylene-androsta-1,4-diene-3,17-dione
MFCD00866994
6-Methyleneandrosta-1,4-diene-3,17-dione
EXALAMIDE
6-methylideneandrosta-1,4-diene-3,17-dione
Androsta-1,4-diene-3,17-dione, 6-methylene-
(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methyliden-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3,17(6H)-dion
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
453.7±45.0 °C at 760 mmHg
[ Melting Point ]:
155.13°C
[ Molecular Formula ]:
C20H24O2
[ Molecular Weight ]:
296.403
[ Flash Point ]:
169.0±25.7 °C
[ Exact Mass ]:
296.177643
[ PSA ]:
34.14000
[ LogP ]:
3.11
[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C
[ Index of Refraction ]:
1.572
[ Storage condition ]:
Store at -20°C
Safety Information
[ Symbol ]:
GHS07, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H319-H360
[ Precautionary Statements ]:
P201-P305 + P351 + P338-P308 + P313
[ Hazard Codes ]:
T,N
[ Risk Phrases ]:
60-61-51
[ Safety Phrases ]:
S26-S36/37/39
[ RIDADR ]:
UN 3261 8/PG 2
[ WGK Germany ]:
3
[ Packaging Group ]:
III
[ Hazard Class ]:
8
[ HS Code ]:
2937900090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2937900090
[ Summary ]:
HS: 2937900090 Tax rebate rate:9.0% Supervision conditions:q(report of inspection of soundness on import medicines) VAT:17.0% MFN tariff:4.0% General tariff:30.0%
Articles
J. Chromatogr. A. 1374 , 40-9, (2014)
Simple, fast and efficient sample preparation approaches that allow high-throughput isolation of various compounds from complex matrices are highly desired in bioanalysis. Particularly sought are meth...
Mol. Med. Report. 12 , 456-62, (2015)
Breast cancer is associated with high levels of incidence, morbidity and mortality; therefore, the identification of effective chemopreventive strategies is crucial. It is important for clinicians to ...
N. Engl. J. Med. 371(2) , 107-18, (2014)
Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women with hormone-receptor-positive breast cancer.In two phase 3 trials, we randomly assi...